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Scintigraphic E valuation  o f  E xperim ental C o litis  
in R abbits
Wim J.G. Oyen. Otto C. Boerman, Els T.M. Dams. Gert Storm. Louis van Bloois, Emile B. Koenders,
Urbain .I.G.M. van Haelst, Jos W.M. van der Meer and Frans H.M. Corstens
University Hospital Nijmegen, Departments o f  Nuclear Medicine, Internal M edicine and  Pathology, Nijmegen; and  Utrecht 
University, Institute f o r  Pharm aceutical Science (UIPS), Department o f  Pharmaceutics, Utrecht, The Netherlands
Scintigraphic techniques are frequently used for evaluation of in­
flammatory bowel disease. The radiopharmaceutical of choice is 
labeled leukocytes. In this study, two new agents, 1111n-labeled 
polyethylene glycol-coated liposomes and 111 In-labeled human 
nonspecific gamma globulin (immunoglobulin G; IgG), were com ­
pared with 111ln-leukocytes in a rabbit model of colitis. Methods: In 
rabbits, acute colitis was induced by colonic instillation of trinitro­
benzene sulfonic acid at 25 cm from the anal sphincter. After 24 hr, 
15 MBq of the radiopharmaceuticals was injected intravenously in 
groups of four rabbits. Twenty-four hours after injection, the animals 
were killed and macroscopic abnormalities were scored in seven 
consecutive affected colonic segments of 5 cm each (0 = normal,
1 =  inflammation, 2 = ulcers). The ex vivo uptake was measured in 
the normal ascending colon and the affected colonic segments. The 
colitis index (Cl, affected-to-normal eolon-uptake ratio) was calcu­
lated. Results: Histologically, an acute, patchy, transmural colitis 
was observed at the site of instillation and the distal colon. The Cl of 
all agents in colitis lesions correlated with the severity of the 
abnormalities. With increasing severity, the Cl for liposomes was
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1.86 ±  0.24, 4.88 ±  0.42 and 7.42 ±  0.54 (r2 =  0.68, p <  0.001); for 
leukocytes 1.77 ±  0.32, 3.10 ± 0.58 and 5.54 ±  0.83 (r2 =  0.31, p <  
0.01); for IgG 1.60 ±  0.29, 2.81 ±  0.21 and 2.65 ±  0.21 (r2 =  0.29, 
p <  0.02). Conclusion: Indium-111-labeled-leukocytes, -IgG and 
-liposomes all show increased uptake in inflamed colonic tissue. 
Indium-111 -liposomes showed the highest Cl, which correlates best 
with the morphological abnormalities. Indium-111-leukocytes and 
111 In-liposomes are superior to 1111n-IgG for this indication.
Key Words: radionuclide imaging; diagnostic imaging; gamma 
globulin; indium-111; scintigraphy; inflammatory bowel disease
J Nucl Med 1997; 38:1596-1600
Inflammatory bowel disease is a condition with fluctuating 
episodes of relapses and remissions of acute colitis. In clinical 
practice, diagnostic procedures are most helpful for evaluating 
the status of the diseased colon. The major diagnostic tools are 
endoscopy (allowing direct inspection of the diseased mucosa), 
radiographic evaluation using barium enemas (providing im­
ages of the morphological abnormalities) and scintigraphic 
modalities (showing functional images of the degree of inflam­
matory activity in affected areas in the gut). For the latter 
technique, a variety of radiopharmaceuticals are available.
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W hen scintigraphic evaluation o f  the abdom en is considered  
labeled leukocytes are currently the agent o f  ch o ice , since high  
sensitiv ity  and sp ecific ity  is observed, esp ecia lly  in acute colitis  
( / ) .  U nfortunately, the preparation o f  radiolabeled autologous  
leukocytes has several d isadvantages that limit its application. 
In particular, the necessity  to draw and handle possib ly  co n ­
taminated blood constitutes an inherent risk to other patients 
and sta ff  (2, J). M oreover, isolation and labeling o f  leukocytes is 
a relatively com plicated  and tim e-consum ing procedure that is 
not possib le  in every nuclear m edicine facility  (4). To overcom e  
these d ifficu lties, research has been directed toward develop ing  
agents that are as equally e ffective , but easier to produce from  
instant, ready-to-use radiolabeling kits.
In this study in a rabbit m odel o f  acute colitis, the targeting  
o f  111 In-labeled-leukocytes is com pared with the perform ance  
o f  tw o recently d evelop ed  radiopharm aceuticals: " in -lab eled  
human nonspecific  polyclonal gam m a globulin  (im m u n oglob ­
ulin G; IgG) and 111 In-labeled sterically stabilized liposom es. 
Ind ium -111 -IgG lias already been applied in clinical practice 
for the d iagnosis o f  a w ide variety o f  in fectious and inflam m a­
tory processes (5). Labeled liposom es have also been investigated 
in patients (6,7). However, these conventional liposom es, as used 
in the past, are rapidly cleared from the circulation by phagocytic 
cells o f  the mononuclear phagocyte system  (#). The advantage o f  
sterically stabilized liposom es is the prolonged residence time in 
circulation with consequently higher levels o f  uptake in inflamma­
tory foci and low liver and spleen uptake (9-11) .
MATERIALS AND METHODS 
Animal Model
In female N ew  Zealand white rabbits (weight 2 .5 -3  kg), acute 
colitis was induced as described previously with minor modifica­
tions (12-14).  Experiments were performed in accordance with the 
local animal welfare committee guidelines. During the experiment, 
the rabbits were fasted, but had water ad libitum. Animals were 
anesthetized with an intravenous injection o f  a 0.7-ml mixture o f  
fentanyl 0.315 mg/ml and fluanisone 10 mg/ml (Hypnorm). After 
retrograde insertion o f  a flexible silicone tube, 1 ml o f  30 mg 
trinitrobenzene sulfonic acid in 30% ethanol, followed by 1 ml 
50% ethanol flush, was instilled in the colon 25 cm from the anal 
sphincter. Thereafter, anesthesia was terminated by intravenous 
injection o f  0.2 ml o f  naloxon hydrochloride 0.4 mg/ml (Narcan). 
Twenty-four hours after colitis induction, the respective radiophar­
maceuticals were injected through the ear vein.
Radiopharmaceuticals
Indium-111-Leukocytes. One hundred milliliters o f  blood were 
drawn carefully from an anesthetized donor rabbit by carotic artery 
cannulation in 60 ml syringes, each containing 10 ml 0.33%  
m ethylcellulose in citric acid dextrose. The total leukocyte count o f  
the donor rabbit was 10 X 10'Vliter, with approximately 50% 
granulocytes. Preparation o f  the labeled leukocytes was performed 
as described previously (15,16).  In brief, after sedimentation o f  the 
erythrocytes, the supernatant was removed. The remaining cell 
suspension was centrifuged twice and the cell pellet was washed 
with phosphate buffered saline ( P B S )/1 % HSA. Indium-111-oxine 
( 100 M Bq) in 0.2 M  tris(hydroxymethyl)aminomethane hydrochlo­
ride (pH =  8.0) was added to the ccll suspension. After a 30-min  
incubation period, the cells were incubated at room temperature for 
30 min, centrifuged and resuspended in PBS/1% human serum 
albumin. Morphological integrity o f  the leukocytes was checked by 
light microscopic examination. Labeling efficiency (cell associated 
activity/total activity X 100%) was higher than 95%. Indium-11 1- 
leukocytes (15 MBq) were administered intravenously.
Indium-111-Liposomes. Partially hydrogenated egg-phosphati- 
dylcholine with an iodine value o f  40 was derived (17). The 
polyethylene glycol 1900 derivative o f  distearoyl phosphatidylcth- 
anolamine was prepared as described previously (/(V). A chloro­
form/methanol mixture ( 10/ 1, v/v) containing polyethylene glycol- 
distearoyl phosphatidylethanolamine, partially hydrogenated egg- 
phosphatidylcholinc and cholesterol was prepared in a molar ratio 
o f  0.15:1.85:1. A lipid film was formed by rotary evaporation 
followed by high vacuum to remove residual organic solvent (19). 
The lipids were dispersed at room temperature in 6 mM  Desferal in
0.9% HEPES buffer ( 10 m M  HEPES/135 m A/sodium  chloride, pH 
7.5) at an initial phospholipid concentration o f  120 mA/. The 
liposom es were sequentially extruded through polycarbonate filters 
o f  0.2, 0 . 1, 0.08 and 0.05-/xm pore size. Unentrapped Desferal was 
removed by gel filtration on an EconoPac 10 DG column. The 
particle size distribution was determined by dynamic light scatter­
ing with a Malvern 4700 system using a 25 mW Helium-Neon  
laser. The data were analyzed using the Automeasure 3.2 software. 
As a measure o f  particle size distribution o f  the dispersion, a 
polydispersity index was determined, ranging from 0.0  (entirely 
monodisperse dispersion) to 1.0 (com pletely polydisperse disper­
sion). The mean size o f  the liposome dispersions was 90 nm with 
a polydispersity index o f  approximately 0 . 1.
Prcfonned Desferal-containing liposomes were labeled with 
11'in essentially as described previously (10.20).  Indium-1 11 was 
transported over the lipid bilayer in the form o f  m In-oxine and 
trapped irreversibly in the internal aqueous phase by the encapsulated 
Desferal. Briefly, the liposomes (45 mmol phospholipid/ml) were 
incubated for 30 min at room temperature with 200 kBq m In-oxine 
per millimole o f  phospholipid. Removal o f  unencapsulated Mlln- 
oxine was achieved by gel filtration on a 10DG Econo Pak column. 
More than 95% o f  the radiolabel was associated with the liposomes. 
Indium-111-liposomes (15 MBq) were injected intravenously.
Indium-111-IgG. Human, nonspecific polyclonal IgG was con­
jugated to diethylenetriaminepentaacetic bicyclic anhydride (bicy- 
clic DTPA) as described by Hnatowich et al. and labeled with 
111 In-chloride (21). Labeling efficiency as determined by instant 
thin-layer chromatography was higher than 95%. Indium-1 I 1-IgG 
(15 MBq) was injected intravenously.
Histology
Two rabbits were killed with an overdose o f  sodium phénobar­
bital 24 hr after colitis induction. The colon was resected and 
tissues were fixed in 4% formaldehyde in PBS. Tissue samples 
were embedded in paraffin and 5-^un sections were stained with 
hematoxylin-cosin for light-microscopic examination.
Imaging Procedure and Biodistribution
Twenty-four hours after colitis induction, three groups o f  four 
rabbits were intravenously injected through the ear vein with either 
111 In-leukocytes, 111 In-liposomes or IMIn-IgG. The rabbits were 
immobilized in a mold and placed prone on a gamma camera 
equipped with a parallel-hole medium-energy collimator. Each 
rabbit was imaged at 5 min, 1 hr, 4 hr, 10 hr and 20 hr after 
injection. Images (100,000 counts per rabbit) were obtained and 
stored in a 256 X 256 matrix.
After acquiring the final images, the rabbits were killed with an 
overdose o f  sodium phénobarbital and biodistribution o f  the 
radiopharmaceuticals was determined. Blood was obtained by 
cardiac puncture. Tissues [muscle, lung, liver, spleen, kidney, 
normal (ascending) colon and affected (transverse and descending) 
colon] were dissected. The affected colon was divided into seven 
consecutive affected colonic segments o f  5 cm each. The colonic 
segments were scored macroscopically on an arbitrary scale (0  =  
normal, 1 =  inflammation, 2 =  ulcers). The samples were weighed  
and their radioactivity was measured in a shielded well scintillation
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FIGURE 1. Histology of trinitrobenzene sulfonic acid-induced acute colitis. 
The mucosa shows beginning necrosis and ulceration (arrows). The submu­
cosa is edematous (*). Areas of granulocyte infiltration can be identified 
throughout the colonic wall. Hematoxylin-eosin-stained transverse sections: 
(A) X130, (B) x330.
gamma counter. To correct for physical decay and to permit 
calculation of the uptake of the radiopharmaceuticals in each organ 
as a fraction of the injectcd dose, aliquots of the injected dose were 
counted simultaneously. The results were expressed as percent 
injected dose per gram (%ID/g). From these results, the colitis 
index (Cl. affected-to-normal colon ratio) for each of the radio- 
pharmaceuticals was calculated in all segments.
Statistical Analysis
All mean values are given as %II)/g or ratios ± one s.e.m. 
Statistical analysis was performed using one way analysis of 
variance. Correlations were calculated by linear regression analy­
sis. The level of significance was set at p <  0.05.
RESULTS
Histologically, multiple areas of mucosal necrosis were ob­
served at the site of instillation and the part of the colon between 
instillation site and rectum. The submucosa was edematous and 
transmural granulocytic infiltration was seen (Fig. I).
Over time, increasing accumulation of the radiopharmaceu­
ticals in the diseased colon was observed on the scintigraphic 
images. Figure 2 shows images of rabbits recorded 1 0  and 20 hr 
after injection of the radiopharmaceuticals. Physiological up­
take in kidneys (liposomes and lgG only), liver and spleen was 
seen. Furthermore, affected parts of the colon were delineated 
with all radiopharmaceuticals.
The biodistribution in tissue samples is given in Table l. 
Indium-111-leukocyte blood levels were lower than those of 
111 In-IgG and 111 In-liposomes. This faster clearance of 111 In­
leukocytes was also rellected in significantly lower uptake in
D E
FIGURE 2. Scintigraphic images of rabbits with experimental colitis. (A) 
Indium-111 leukocytes, 10 hr postinjection. (B) Indium-111 leukocytes, 20 hr 
postinjection. (C) Indium-111 liposomes, 10 hr postinjection. (D) Indium-111 
liposomes, 20 hr postinjection. (E) Indium-111 lgG, 10 hr postinjection. (F) 
Indium-111 lgG, 20 hr postinjection. Note the physiological uptake in liver, 
spleen and for 1111n-liposomes and 11’ In-IgG also kidney and blood pool. 
=>S = liver; * = spleen; —> = delineation of colitis.
muscle, lung and uptake in nonaffected normal colon. The 
uptake in liver and spleen markedly differed between the 
various preparations. Indium-111-leukocytes had much higher 
splenic and—to a lesser extent— liver uptake than 111 In-lipo- 
somes and m In-IgG. Overall absolute uptake in the affected 
colon was significantly higher for 111 In-liposomes than for the 
two other agents. Absolute uptake of 111 In-leukocytes was rela­
tively low. Still, as indicated below, abnormalities were also well 
delineated with 111 In-leukocytes, since uptake in nonaffected colon 
was extremely low and consequently CIs relatively high.
CIs (diseased-to-normal colon ratios) are given in Figure 3. 
When comparing the relative uptake in macroscopically normal 
colon (scored as Grade 0), the CIs for all three preparations 
were similar. In nonulcerative inflammation (scored as Grade 1) 
and ulceration (scored as Grade 2), the relative uptake of 
111 In-liposomes in the diseased segments was higher than that 
of both 111 In-leukocytes and m In-IgG, reflected in significantly 
higher CIs of 111 In-liposomes (p <  0.05 and p <  0.001, respec­
tively). The relative uptake of m In-IgG was significantly lower 
than that of 111 In-leukocytes in ulceration (Grade 2) (p <  0.05).
When evaluating the relative uptake in the affected segments 
for the individual radiopharmaceuticals, a positive correlation 
was observed between CIs and the severity of the macroscopic 
abnormalities. For 111 In-liposomes, correlation was strongest 
(r2 = 0.68, p <  0.001). Similarly, for 111 In-leukocytes and 
m In-IgG, a correlation was observed but less striking (r2 =  
0.31, p <  0.01, and r2 =  0.29, p <  0.02, respectively).
DISCUSSION
In this study, 111 In-labeled sterically stabilized liposomes 
were show'n to be a superior imaging agent for evaluation of
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Tissue Distribution (%ID/g; mean ±  s.e.m.) Obtained 48 hr after Colitis Induction and 24 hr after Injection of the Radiopharmaceuticals
TABLE 1
Tissue 1111n-IgG P* 1111n-leukocytes Pr
^ In -
liposomes
Blood 0.22 ± 0.03 <  0.05 0.13 ± 0.008 < 0.05 0.22 ± 0.01
Muscle 0.01 ± 0.001 < 0.01 0.002 ± 0.0002 <  0.01 0.01 ± 0.001
Lung 0.09 ± 0.001 <  0.01 0.06 ± 0.002 < 0.01 0.10 ± 0.001
Liver 0.20 ± 0.02 <  0.01 0.53 ±  0.04 < 0.01 0.15 ± 0.03
Spleen 0.12 ± 0.008 < 0.01 8.08 ± 1.09 <  0.01 0.42 ± 0.04*
Kidney 0.19 ± 0.02 < 0.01 0.05 ± 0.006 < 0.01 0.20 ± 0.02
Ascending colon 0.05 ± 0.002 < 0.01 0.01 ± 0.003 <  0.01 0.06 ± 0.007
(normal)
Descending colon 0.13 ± 0.01 < 0.01 0.03 ± 0.006 <  0.01 0.37 ±  0.003*
(affected, 35 cm)
IgG = gamma globulin.
*111ln-lgG vs. 111ln-leukocytes.
1111 In-leukocytes vs. 111 In-liposomes.
*1111n-liposomes vs. 1111n-IgG (p <  0.01).
acute trinitrobenzene sulfonic acid-induced colitis in rabbits. In 
clinical practice, leukocytes arc considered the standard tech­
nique for scintigraphic evaluation of disease activity in inflam­
matory bowel disease (1.22).  In this study, 111 In-liposomes 
showed higher absolute, as well as uptake, ratios in diseased 
colonic segments compared with the 111 In-leukocytes. More­
over, correlation of the macroscopic abnormalities observed in 
the affected colon and relative colonic uptake, of 1 , 1 In-lipo­
somes was better compared with 111 In-leukocytes. In addition, 
hepatosplenic uptake of 111 In-liposomes was considerably 
lower than that of 111 In-leukocytes, which is not only important 
for adequate scintigraphic evaluation of the alimentary tract in 
the upper abdomen, but also for reduction of the radiation 
burden to the spleen and to long-living T-lymphocytes, which 
are also labeled in mixed leukocyte preparations (23). Despite 
the lower absolute uptake of 111 In-leukocytes in colitis lesions, 
diseased colon segments could be delineated well since uptake 
in the background tissues (i.e., normal colon and muscle) was 
extremely low, providing sufficient contrast. Abnormalities 
were depicted early on the 111 In-leukocyte images due to the 
relatively fast blood clearance. A major advantage of '" ln -  
liposomes is the ease of preparation of a high-quality radio­
pharmaceutical without the need to isolate and handle blood.
The superiority of 111 In-leukocytes over labeled gamma
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FIGURE 3. Cl (mean ± s.e.m.) of the radiopharmaceuticals as compared 
with the macroscopic severity of abnormalities in the affected colon. (Grade 
0 = normal; Grade 1 = inflammation; Grade 2 = ulcers.)
globulin confirms clinical results with labeled gamma globulin 
(5,24). The abnormalities depicted by the labeled leukocytes 
scintigraphy were shown to correlate better with disease activity 
than those observed on labeled gamma globulin images, indi­
cating relatively low sensitivity and specificity of the latter 
agent (24,25). In this study, this was exemplified by the lower 
relative uptake of 1 1 1 1n-IgG in affected colon as compared with
111 In-leukocytes (and 111 In-liposomes). This lower ratio will ob­
viously make it more difficult to differentiate accumulation in 
inflamed from nonnal tissue uptake. Moreover, even the limited 
physiological excretion of labeled gamma globulin in the gut may 
interfere with adequate evaluation of diseased colon (5).
The mechanism of accumulation in the target area of 1 1 'in- 
leukocytes and the two new radiopharmaceuticals is entirely 
different (26). Adequate ' " In-leukocytes scintigraphy requires 
viability of the cells with intact chemotactic capacities, since the 
labeled cells must actively migrate to an inflammatory target 
similar to unlabeled leukocytes. When damaged, the labeled 
cells show prolonged margination in the lungs, followed by 
enhanced clearance by the mononuclear phagocytic system 
(27). This further emphasizes the need for careful preparation of 
leukocytes during labeling. Indium-111-liposomes and 1 1 1 1n- 
IgG both accumulate in inflamed tissue by virtue of increased 
vascular permeability (26). Thus, prolonged intravascular ac­
tivity will be beneficial for the degree of uptake in inflamma­
tion. This also explains why agents like labeled colloids (also a 
particulate radiopharmaceutical) do not provide adequate delin­
eation of colitis (2X,2V). Colloids have a short circulation time 
and distribute rapidly to liver, spleen and bone marrow without 
sufficient focal uptake in disease. Similar characteristics can be 
observed with non-PEGylated larger liposomes (6,7). Whether 
any specific uptake of labeled liposomes in inflammatory cells 
plays a role in accumulation of the radiopharmaceutical in 
inflammatory foci remains to be established.
CONCLUSION
Indium-111-liposomes were superior to 111 In-leukocytes for 
scintigraphic evaluation of acute colitis due to high focal uptake 
and relatively low accumulation in many organs. In addition, in 
view of the ease of preparation, this new formulation is 
particularly attractive for progression to clinical studies. In­
dium-1 11 n-IgG was not very well suited for imaging colitis, 
because the uptake in diseased segments was relatively low and
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